Skip to main content
Caplight Logo









EVQLV

EVQLV

Private
New York City, New YorkHealthcare & Life Scienceshttps://evqlv.com/

Last Round

Seed

Apr 19, 2024

Total Funding Raised

$3.67M

Company Overview

EVQLV is a biotechnology company that uses AI to accelerate the speed and success of antibody discovery for life-science researchers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

AI antibody designtherapeutic antibody designAI drug discoveryantibody marketplacegenerative biologyAI biotechAI drug discovery platformin silico drug discoverybiologics discoveryantibody engineeringde novo antibody discoveryantibody optimizationcontract research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EVQLV Comparables

Compare EVQLV with similar companies based on industry and business-model similarity.

EVQLV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ARLAN BIOTECH
88%
NaturalAntibody
79%
Antiverse
78%

EVQLV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 19, 2024
SeedFeb 14, 2023
GrantJun 29, 2021
Pre SeedFeb 8, 2021

Key People

Founding team and executive leadership

Andrew Satz

Co-Founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 40% MoM.

  • Jan 24, 2026

    Monthly visitors increased 71% MoM.

EVQLV Filings

Explore SEC and related filing metadata, where available.

EVQLV filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EVQLV's valuation, stock price, and market status.

Is EVQLV a public or private company?

EVQLV is a private company.

What is the current stock price of EVQLV?

EVQLV is a private company with no public stock price. No recent secondary market data is available.

How much is EVQLV worth (valuation)?

Valuation information for EVQLV is not publicly available.

Can I buy EVQLV stock?

EVQLV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EVQLV's last funding round?

Funding round information for EVQLV is not publicly available.

Who are the main investors in EVQLV?

Investor information for EVQLV is not publicly disclosed.

Will EVQLV IPO soon?

No public IPO plans have been announced for EVQLV.

How can I track EVQLV secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EVQLV's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range3
Year Founded2019
Last FundingApr 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?